Diluted EPS came in at $-1.81.
Trailing eight quarters through Q2 2024
Common questions about Climb Bio, Inc.'s Q2 2024 earnings report.
Climb Bio, Inc. (CLYM) reported Q2 2024 earnings on August 14, 2024 before market open.
Climb Bio, Inc. reported diluted EPS of $-1.81 for Q2 2024.
You can read the 10-Q periodic report (0000950170-24-096626) directly on SEC EDGAR. The filing index links above go to sec.gov.